These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2037683)

  • 1. Use of a new synthetic-peptide-derived monoclonal antibody to differentiate between vaccine and wild-type Venezuelan equine encephalomyelitis viruses.
    Roehrig JT; Bolin RA; Hunt AR; Woodward TM
    J Clin Microbiol; 1991 Mar; 29(3):630-1. PubMed ID: 2037683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses.
    Hunt AR; Roehrig JT
    Vaccine; 1995 Feb; 13(3):281-8. PubMed ID: 7543231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide.
    Hunt AR; Johnson AJ; Roehrig JT
    Virology; 1990 Dec; 179(2):701-11. PubMed ID: 2146802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.
    Kinney RM; Esposito JJ; Mathews JH; Johnson BJ; Roehrig JT; Barrett AD; Trent DW
    J Virol; 1988 Dec; 62(12):4697-702. PubMed ID: 3184276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies capable of distinguishing epizootic from enzootic varieties of subtype 1 Venezuelan equine encephalitis viruses in a rapid indirect immunofluorescence assay.
    Roehrig JT; Bolin RA
    J Clin Microbiol; 1997 Jul; 35(7):1887-90. PubMed ID: 9196217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus.
    Bennett AM; Lescott T; Phillpotts RJ
    Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoproteins E2 of the Venezuelan and eastern equine encephalomyelitis viruses contain multiple cross-reactive epitopes.
    Pereboev AV; Razumov IA; Svyatchenko VA; Loktev VB
    Arch Virol; 1996; 141(11):2191-205. PubMed ID: 8973533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic peptides of the E2 glycoprotein of Venezuelan equine encephalomyelitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication.
    Hunt AR; Short WA; Johnson AJ; Bolin RA; Roehrig JT
    Virology; 1991 Nov; 185(1):281-90. PubMed ID: 1718085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. III. Identification of a protective peptide derived from the carboxy-terminal extramembranal one-third of the protein.
    Johnson AJ; Hunt AR; Roehrig JT
    Virology; 1991 Dec; 185(2):840-2. PubMed ID: 1962453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.
    Kinney RM; Chang GJ; Tsuchiya KR; Sneider JM; Roehrig JT; Woodward TM; Trent DW
    J Virol; 1993 Mar; 67(3):1269-77. PubMed ID: 7679745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83.
    Kinney RM; Johnson BJ; Welch JB; Tsuchiya KR; Trent DW
    Virology; 1989 May; 170(1):19-30. PubMed ID: 2524126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine.
    Burke DS; Ramsburg HH; Edelman R
    J Infect Dis; 1977 Sep; 136(3):354-9. PubMed ID: 903673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1998 Aug; 16(13):1314-23. PubMed ID: 9682396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines.
    Ferguson JA; Reeves WC; Hardy JL
    Am J Vet Res; 1977 Apr; 38(4):425-30. PubMed ID: 851275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The differentiation of viruses in the Venezuelan equine encephalomyelitis complex by using monoclonal antibodies and lanthanide immunofluorescence analysis].
    Gaĭdamovich SIa; Pomelova VG; Lavrova NA; Mel'nikova EE; Sokolova MV; Kharitonenkov IG; Zlobin VN
    Vopr Virusol; 1991; 36(3):226-9. PubMed ID: 1716393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Venezuelan equine encephalitis virus subtype IE with two equine epizootics in Mexico.
    Oberste MS; Fraire M; Navarro R; Zepeda C; Zarate ML; Ludwig GV; Kondig JF; Weaver SC; Smith JF; Rico-Hesse R
    Am J Trop Med Hyg; 1998 Jul; 59(1):100-7. PubMed ID: 9684636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical and oligonucleotide fingerprint analyses of Venezuelan equine encephalomyelitis complex viruses.
    Trent DW; Clewley JP; France JK; Bishop DH
    J Gen Virol; 1979 May; 43(2):365-81. PubMed ID: 90115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venezuelan equine encephalitis-specific immunoglobulin responses: live attenuated TC-83 versus inactivated C-84 vaccine.
    Engler RJ; Mangiafico JA; Jahrling P; Ksiazek TG; Pedrotti-Krueger M; Peters CJ
    J Med Virol; 1992 Dec; 38(4):305-10. PubMed ID: 1474379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates.
    Turell MJ; Ludwig GV; Kondig J; Smith JF
    Am J Trop Med Hyg; 1999 Jun; 60(6):1041-4. PubMed ID: 10403340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1995; 13(15):1411-20. PubMed ID: 8578818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.